Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population: Insights From the ARIC (Atherosclerosis Risk in Communities) Study
- 22 December 2009
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 54 (25), 2388-2395
- https://doi.org/10.1016/j.jacc.2009.10.006
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Prevalence of Low Low-Density Lipoprotein Cholesterol With Elevated High Sensitivity C-Reactive Protein in the U.S.: Implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) StudyJournal of the American College of Cardiology, 2009
- From Here to JUPITERCirculation: Cardiovascular Quality and Outcomes, 2009
- Expanding the Orbit of Primary Prevention — Moving beyond JUPITERThe New England Journal of Medicine, 2008
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Prediction of Coronary Heart Disease in Middle-Aged Adults With DiabetesDiabetes Care, 2003
- Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994The New England Journal of Medicine, 1998
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experienceJournal of Clinical Epidemiology, 1996
- Prevalence of stroke and transient ischemic attacks in the atherosclerosis risk in communities (ARIC) studyAnnals of Epidemiology, 1993